Feed

Show only
16/01/2020
Le novità del De­creto Fisc­ale 2020 con­ver­tito - Prima...
15 Jan 20
Can newly dis­covered can­nabis com­pounds be pro­tec­ted by pat­ents?
A break­through dis­cov­ery has re­cently hit the news: tet­rahy­drocan­nabi­phorol (THCP) and can­na­bid­i­phorol (CB­DP), two new can­nabin­oid com­pounds, have been dis­covered in Can­nabis sativa and char­ac­ter­ised...
10/01/2020
CMS cresce ancora nel Tax in Italia e apre il 2020...
13 Jan 20
In-depth in­vest­ig­a­tion by the European Com­mis­sion in­to EUR 9 mil­lion...
On 20 Decem­ber 2019, the European Com­mis­sion's de­cision to ini­ti­ate the form­al in­vest­ig­a­tion pro­ced­ure re­gard­ing a EUR 9 mil­lion aid from the Valen­cia Re­gion to Air Nos­trum for the re­new­al of its fleet,...
CMS Ex­pert Guide to La­bour Law in Cent­ral East­ern Europe
06 Jan 20
Land­mark cli­mate change judg­ment: Dutch gov­ern­ment again com­pre­hens­ively...
On 20 Decem­ber 2019, the highest court (Su­preme Court) in the Neth­er­lands dis­missed the Dutch Gov­ern­ment’s fi­nal ap­peal in the land­mark cli­mate change case, Ur­genda Found­a­tion v The Neth­er­lands. This...
10/01/2020
Heir of soph­ist­ic­a­tion
Tax­a­tion of art
23 Dec 19
So­cial Me­dia and mHealth Data EMA / HMA Re­port
New and in­nov­at­ive tech­no­lo­gies have led to a huge in­crease in data com­ing from sources that haven’t pre­vi­ously been used with­in the reg­u­lated medi­cines in­dustry. In re­cog­ni­tion of this ex­plo­sion of...
23/12/2019
CMS al fianco del Gruppo Voith nell’ac­quis­iz­ione di...
23 Dec 19
A new EU op­er­a­tion­al re­si­li­ence frame­work for cy­ber se­cur­ity?
Our re­cent Law-Now art­icle dis­cussed the FCA, PRA and Bank of Eng­land con­sulta­tions on im­prov­ing fin­an­cial sta­bil­ity in the UK mar­kets through op­er­a­tion­al re­si­li­ence. Con­tinu­ing this theme, but now from...
18/12/2019
Le pro­ced­ure di al­lerta prev­iste dal Co­dice della crisi...
20 Dec 19
‘Dar­unavir’ CJEU re­fer­ral with­drawn - Art­icle 3(a) of the SPC Reg­u­la­tion
At the end of Septem­ber, we re­por­ted here on the pub­lic­a­tion of AG Hogan’s Opin­ion on the joint re­fer­rals from the Ger­man Bundes­pat­ent­gericht (case C-650/17) for Mer­ck’s sitaglipt­in product and from...